HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

2- (7- (3,4- dimethoxyphenyl)imidazo(1,2- c)pyrimidin- 5- ylamino)nicotinamide

a spleen tyrosine kinase inhibitor; structure in first source
Also Known As:
BAY 61-3606; BAY-61-3606; BAY61-3606
Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Robak, Ewa: 1 article (07/2012)
2. Robak, Tadeusz: 1 article (07/2012)
3. Haigis, Kevin M: 1 article (01/2012)
4. Gope, Rajalakshmi: 1 article (01/2012)
5. Gray, Nathanael S: 1 article (01/2012)
6. Zhang, Tinghu: 1 article (01/2012)
7. Mitra, Rohan: 1 article (01/2012)
8. Kendall, Krystle R: 1 article (01/2012)
9. Lau, Ken S: 1 article (01/2012)
10. Lauffenburger, Douglas: 1 article (01/2012)

Related Diseases

1. Colorectal Neoplasms (Colorectal Cancer)
2. Acoustic Neuroma (Acoustic Neurinoma)
3. Inflammation
4. Hypersensitivity (Allergy)
5. Edema

Related Drugs and Biologics

1. Sodium
2. Butyrates (Butyrate)
3. Antigens
4. PCI 32765
5. R788 compound
6. bafetinib
7. 4- methyl- N- (3- (4- methylimidazol- 1- yl)- 5- (trifluoromethyl)phenyl)- 3- ((4- pyridin- 3- ylpyrimidin- 2- yl)amino)benzamide (nilotinib)
8. dasatinib (BMS 354825)
9. SU 6656
10. LFM A13

Related Therapies and Procedures

1. Oral Administration